More New Yorkers with AIDS died of 'common' causes in 2004 than in 1999

September 18, 2006

PHILADELPHIA, September 19, 2006 -- An analysis of 68,669 New York City residents with AIDS found that of those who died between 1999 and 2004, 26.3 percent died of non-HIV-related causes. This figure is a 32.8 percent increase from 19.8 percent in 1999.

The analysis, "Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy: New York City," is published in the Sept. 19, 2006, issue of Annals of Internal Medicine.

More than three quarters of non-HIV-related deaths were due to three underlying causes: substance abuse (31 percent), cardiovascular disease (23.8 percent), or a non-HIV-related type of cancer (20.8 percent).

"Reducing deaths from these causes requires a shift in the health care model for persons with AIDS from a primary focus on managing HIV infection to providing care that addresses all aspects of physical and mental health," said Judith E. Sackoff, Ph.D., lead author of the analysis. "This should include helping patients change behaviors, such as smoking; screening for early detection of cancer; and monitoring chronic conditions, such as diabetes and hypertension."

In a separate editorial, Judith A. Aberg, M.D., concurred. "Physicians everywhere must remember that most of their HIV-infected patients will survive to develop the diseases that plague the rest of us."
NOTE TO EDITORS: To interview Judith E. Sackoff, Ph.D. or Harold Sox, M.D., Editor of Annals of Internal Medicine, contact Steve Majewski.

American College of Physicians

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to